Ajinomoto CELLiST Korea launches CELLiSTTM AAV production supplement 1 to improve gene therapy manufacturing efficiency

Ajinomoto, founded in 1909 after chemist Kikunae Ikeda isolated glutamate from kelp broth and commercialized it as MSG, has evolved from seasoning to cell culture media over more than a century Now, its Korean subsidiary Ajinomoto CELLiST Korea, which focuses on cell culture media development and manufacturing, announced the launch of CELLiSTTM AAV Production Supplement… The post Ajinomoto CELLiST Korea launches CELLiSTTM AAV production supplement 1 to improve gene therapy manufacturing efficiency appeared first on Drug Discovery and Development.

Continue reading →